Synonyms:enoxacin, 74011-58-8, Penetrex, Enoxacine, Comprecin, 1-Ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid, AT-2266, Bactidan, Enoxacino, Enoxacinum, Flumark, Enoxor, CI-919, Almitil, PD 107779, CI 919, Enoxacin (Penetrex), PD-107779, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, NSC 629661, Enoxacin (hydrate), CHEBI:157175, CHEMBL826, NSC-629661, NSC-758416, 1-Ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, DTXSID5022984, Enoram, Enoxin, 325OGW249P, NSC629661, 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, AT 2266;CI 919, Enoxacine [French], Enoxacinum [Latin], enofloxacin, NCGC00016927-01, Enoxacino [Spanish], Enoksetin, CAS-74011-58-8, 1,8-Naphthyridine-3-carboxylic acid, 1,4-dihydro-1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-, 1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid, DTXCID002984, Enoxacin sesquihydrate;AT-2266 hydrate;CI-919 hydrate, Bactidron, Enoxen, Penetrex (TN), SMR000058233, CCRIS 5242, Enoxacin (USAN/INN), SR-01000000202, NSC 627409, AT 2266, BRN 3628995, PD107779, Abenox, UNII-325OGW249P, Enoxacin [USAN:INN:BAN:JAN], ENX, Prestwick_708, MFCD00133308, Spectrum_001539, ENOXACIN [USAN], ENOXACIN [INN], ENOXACIN [MI], ENOXACIN [VANDF], Prestwick0_000353, Prestwick1_000353, Prestwick2_000353, Prestwick3_000353, Spectrum2_001731, Spectrum3_001570, Spectrum4_000166, Spectrum5_001044, E0762, ENOXACIN [MART.], ENOXACIN [WHO-DD], Epitope ID:119069, Oprea1_147866, SCHEMBL33963, BSPBio_000445, BSPBio_003080, Enoxacin, analytical standard, KBioGR_000651, KBioSS_002019, MLS000069645, MLS006011976, BIDD:GT0191, DivK1c_000420, SPECTRUM1503215, SPBio_001802, SPBio_002366, ENOXACIN [ORANGE BOOK], BPBio1_000491, GTPL8882, BCBcMAP01_000009, HMS501E22, KBio1_000420, KBio2_002019, KBio2_004587, KBio2_007155, KBio3_002580, NINDS_000420, HMS1569G07, HMS1922I17, HMS2090E10, HMS2092N20, HMS2233K20, HMS3372A12, HMS3655M08, HMS3715H13, Pharmakon1600-01503215, BCP22623, HY-B0268, Tox21_110688, BDBM50296358, CCG-39452, NSC758416, s1756, AKOS015838626, Tox21_110688_1, DB00467, KS-5190, 1-ethyl-6-fluoro-4-oxo-7-piperazinylhydropyridino[2,3-b]pyridine-3-carboxylic acid, IDI1_000420, SMP1_000113, NCGC00016927-02, NCGC00016927-03, NCGC00016927-04, NCGC00016927-05, NCGC00016927-06, NCGC00016927-07, NCGC00016927-08, NCGC00016927-10, NCGC00016927-11, NCGC00023864-03, NCGC00023864-04, NCGC00178309-01, NCGC00178309-02, NCI60_009618, SBI-0051788.P002, DB-055829, FT-0630825, SW196857-3, C06979, D00310, EN300-122627, 1, 6-fluoro-1,4-dihydro- 4-oxo-7-piperazinyl, AB00052328-09, AB00052328_10, AB00052328_11, A837996, Q1639616, SR-01000000202-2, SR-01000000202-3, BRD-K78113049-001-05-5, BRD-K78113049-001-07-1, BRD-K78113049-001-12-1, Z1544404495, 1-ethyl-6-fluoranyl-4-oxidanylidene-7-piperazin-1-yl-1,8-naphthyridine-3-carboxylic acid, 1-Ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro[1,8]naphthyridine-3-carboxylic acid, 1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,8-naphthyridine-3-carboxylic acid, 1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, 1-ETHYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-(1-PIPERAZINYL)
Pubchem:PUBCHEM:3229
Id:94c78a00-7217-5e9f-913f-74fa0dd8eff2
Description:nan
